抗糖尿病市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004579
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

预计 2024 年至 2031 年期间抗糖尿病药物市场的复合年增长率为 12.15%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

该研究报告根据药物类别、给药途径、分销渠道和地理位置对抗糖尿病药物市场进行细分。全球分析包括区域级市场分析——报告涵盖了每个地区的主要国家。根据百万美元以及预测期内的复合年增长率 (%) 对上述每个细分市场的市场份额进行评估,这有助于了解定义市场的重要趋势和关键动态,并提供有关市场趋势和动态的详细信息。

该报告回顾了抗糖尿病药物的类别,即胰岛素、磺酰脲类药物、GLP-1 受体激动剂和 DPP-4 抑制剂,描述了 1 型和 2 型糖尿病的适应症。它研究了口服和注射给药途径,旨在概述有助于提高患者依从性和治疗结果的创新和改进。

对主要地区的市场需求和治疗可及性的区域洞察提供了更细致的视角,反映了医疗保健基础设施、患病率和监管环境的差异。

报告目的

The Insight Partners 的《抗糖尿病市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

抗糖尿病药物市场细分

 

产品

  • 胰岛素

班级

病人

  • 儿科
  • 成人
  • 老年

给药途径

  • 胰岛素泵
  • 胰岛素注射器/胰岛素笔
  • 静脉输液
  • 口服
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

抗糖尿病药物市场:战略洞察

Antidiabetics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

抗糖尿病药物市场增长动力

  • 糖尿病患病率上升:全球糖尿病病例呈上升趋势,尤其是 2 型糖尿病,这通常与肥胖率上升有关。根据国际糖尿病联合会的数据,估计 2021 年有 5.37 亿成年人患有糖尿病,到 2030 年将增加到 6.43 亿。这一令人担忧的趋势凸显了对有效糖尿病管理解决方案的迫切需求。
  • 药物开发过程的改进:这包括(但不限于)GLP-1受体激动剂和SGLT2抑制剂。此类新药为患者提供了更有价值和更精确的治疗选择。例如,这些新药在血糖控制和心血管事件相关结果方面取得了重大改善,提高了患者对治疗方案的依从性。
  • 人口老龄化:由于老年人更容易患糖尿病,几乎所有国家的人口老龄化都可能增加对抗糖尿病药物的需求。据世界卫生组织估计,从 2020 年到 2030 年,60 岁及以上人口的数量将从 10 亿增加到 14 亿。
  • 久坐的生活方式和不良的饮食习惯:久坐的生活方式和不良的饮食习惯加重了糖尿病的负担,并产生了对有效治疗方式的需求。监管机构支持的糖尿病研究投资反过来又通过产生针对不同患者群体的新型疗法促进了整体市场前景。这些因素结合在一起,为抗糖尿病市场的增长创造了非常强劲的环境。

抗糖尿病药物市场未来趋势

  • 先进技术:未来几年,这可能是由于技术进步,包括个性化医疗。市场上观察到的一些热切趋势包括连续血糖监测系统、SGLT-2 抑制剂和 GLP-1 受体激动剂等新类药物的开发,以及对联合疗法的兴趣日益浓厚。
  • 数字健康解决方案:用于糖尿病管理的数字健康解决方案和远程医疗正在兴起。随着糖尿病在世界范围内的流行,人们将越来越关注预防和早期干预,这一过程将形成一种更全面的糖尿病护理方法。其与科技公司的合作将进一步加速创新。
  • 纳米技术在癌症治疗中的应用:纳米药物有望通过增强药物靶向性、降低毒性和改进成像技术来彻底改变癌症治疗。纳米粒子(如金纳米粒子和量子点)越来越多地用于癌症治疗,以实现更有效和局部的治疗。

抗糖尿病药物市场机会

  • 糖尿病管理:全球糖尿病市场日益流行,人们对新型治疗方式的关注度也不断提高,这为抗糖尿病药物市场带来了许多投资机会。随着人们对糖尿病管理的认识不断提高,尤其是 SGLT-2 抑制剂和 GLP-1 受体激动剂等新型药物具有更好的疗效和安全性,对有效药物的需求巨大。
  • 量身定制的治疗:个性化医疗市场日益增长,投资机会也随之增加。个性化医疗市场中,更多量身定制的治疗方案可满足患者的个性化需求,从而改善治疗效果并提高依从性。这一增长可能继续成为令人兴奋的投资领域。此外,随着远程医疗和移动医疗应用等数字医疗解决方案的出现,增长的发生率将进一步提高,因为这些技术允许糖尿病患者远程管理和监控他们的疾病。因此,这些数字技术将提高患者互动和获得护理的水平。
  • 市场扩张:由于医疗保健支出不断增加,中产阶级对更好健康解决方案的需求不断增长,新兴市场拥有多种增长机会。此外,制药公司与科技公司之间的联盟可能会形成综合糖尿病管理系统。最后,由于对新治疗目标和新药配方的发现进行了持续的研究和开发,开发研究充满活力;因此,抗糖尿病市场是实施长期投资战略的肥沃土壤。

 

抗糖尿病药物市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响抗糖尿病药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的抗糖尿病药物市场细分和地理位置。

Antidiabetics Market
  • 获取抗糖尿病药物市场的区域特定数据

抗糖尿病药物市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)12.15%
史料2021-2023
预测期2025-2031
涵盖的领域按产品
  • 胰岛素
按类别按患者
  • 儿科
  • 成人
  • 老年
按给药途径
  • 胰岛素泵
  • 胰岛素注射器/胰岛素笔
  • 静脉输液
  • 口服
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 强生公司
  • 拜耳集团
  • 阿斯利康
  • 赛诺菲
  • 诺华公司
  • 百时美施贵宝公司
  • 默克公司
  • 礼来公司
  • 辉瑞公司

 

抗糖尿病市场参与者密度:了解其对业务动态的影响

抗糖尿病市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在抗糖尿病药物市场运营的主要公司有:

  1. 强生公司
  2. 拜耳集团
  3. 阿斯利康
  4. 赛诺菲
  5. 诺华公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Antidiabetics Market

 

  • 了解抗糖尿病药物市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了抗糖尿病市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,抗糖尿病市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


Which are the key players in Antidiabetics market?

Leading companies in this market are - Johnson & Johnson, Bayer Corporation AG, AstraZeneca, Sanofi, Novartis AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Novo Nordisk

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the deliverable formats of Antidiabetics market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What is expected CAGR in Antidiabetics market?

The market is expected to register a CAGR of 12.15% during 2023-2031

What are the factors impacting on Antidiabetics market?

Key drivers for the antidiabetics market include rising diabetes prevalence, advancements in technology, innovative drug classes, personalized medicine, and increasing adoption of digital health solutions for improved management and prevention.

What are the future trends in Antidiabetics market?

The antidiabetics market is set for growth through advancements in technology, personalized medicine, and innovative drug classes like SGLT-2 inhibitors and GLP-1 receptor agonists. Digital health solutions and telemedicine will enhance diabetes management and prevention efforts.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Johnson & Johnson
2. Bayer Corporation AG
3. AstraZeneca
4. Sanofi
5. Novartis AG
6. Bristol-Myers Squibb Company
7. Merck & Co., Inc.
8. Eli Lilly and Company
9. Pfizer Inc.
10. Novo Nordisk
antidiabetics-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.